Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06598423 · ClinicalTrials.gov registry record · NA

Wavelength Intervention for Nearsighted Kids

A NA study of Myopia, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06598423: Recruiting NA study of Myopia, sponsored by University of Alabama at Birmingham.

NCT06598423 is a NA study of Myopia that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06598423, a NA study of Myopia, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn about the compliance and safety of specialized soft contact lens wear in children. The main questions it aims to answer are: Does wearing specialized soft contact lenses daily slow myopia progression and axial elongation? What visual/ocular problems do participants have when wearing specialized soft contact lenses? Researchers will compare two soft contact lenses to see if specialized soft contact lens wear works to treat childhood myopia progression. Participants will 1. Wear either a single type of soft contact lens or two types of soft contact lenses at alternate times daily full time in both eyes for one year. 2. Visit the clinic at 2 weeks, 1 month, 3 months, 6 months, and 12 months for checkups and tests 3. Keep a diary of the lens-wearing times.

Primary Outcome

Cycloplegic autorefraction measurements will be recorded using the WAM 5500 autorefractor in both eyes at baseline and follow-up visits. A set of 10 spherical equivalent measures will be obtained in each eye and later averaged to obtain the eye's final refractive error.

Conditions Studied

Myopia

Interventions

  • DEVICE Specialized soft contact lens 1
  • DEVICE Specialized soft contact lens 2

Study Locations (1)

Alabama

  • University of Alabama at Birmingham School of Optometry - Birmingham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-04-10
Est. Completion 2027-07-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06598423 shows while recruiting

NCT06598423 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Specialized soft contact lens 1 is the first listed.

NCT06598423 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06598423 about?

NCT06598423 is a clinical study titled "Wavelength Intervention for Nearsighted Kids". The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn about the compliance and safety of specialized soft contact lens wear in children. The main questio...

What is the current status of trial NCT06598423?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-04-10. Estimated completion is 2027-07-31.

What conditions does trial NCT06598423 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT06598423?

The interventions under investigation include: Specialized soft contact lens 1 (DEVICE), Specialized soft contact lens 2 (DEVICE).

Who is sponsoring clinical trial NCT06598423?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06598423 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06598423's enrollment target sits among peer trials

80 46th of 90 higher than 45 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06598423

Source: ClinicalTrials.gov NCT06598423, the US trial registry maintained by the National Library of Medicine. NCT06598423 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.